Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Debernardis

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracilS Cascinu, C Aschele, S Barni, et al.
British Journal of Cancer|January 1, 1997
DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 statusP De Feudis, D Debernardis, P Beccaglia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracilC Aschele, D Debernardis, R Bandelloni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combinationS Cascinu, V Catalano, C Aschele, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracilS Cascinu, C Aschele, S Barni, et al.
British Journal of Cancer|January 1, 1997
DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 statusP De Feudis, D Debernardis, P Beccaglia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracilC Aschele, D Debernardis, R Bandelloni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combinationS Cascinu, V Catalano, C Aschele, et al.
Pageof 2